SCENARIA View Phase vs uMI Panvivo
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
AI Verdict
FUJIFILM SCENARIA View Phase is an AI-powered CT system, excelling in diagnostic radiology with features for dose reduction and cardiac motion correction. In contrast, uMI Panvivo is an AI-powered PET/CT system, providing combined anatomical and functional imaging for oncology, cardiology, and neurology. While both leverage AI for advanced diagnostic imaging in similar clinical domains, their fundamental imaging modalities (CT versus PET/CT) make them distinct solutions.
Choose SCENARIA View Phase if…
Choose FUJIFILM SCENARIA View Phase if your facility prioritizes a high-performance CT system for comprehensive diagnostic radiology, especially when advanced cardiac imaging with motion correction is critical. Its AI-based iterative reconstruction offers significant dose reduction while maintaining high image quality, and features like a wide gantry enhance patient comfort for a broad range of patients.
View SCENARIA View Phase →Choose uMI Panvivo if…
Choose uMI Panvivo if your clinical focus requires an integrated PET/CT system for advanced metabolic and anatomical imaging, particularly for precise oncology staging, treatment response monitoring, or detailed neurological and cardiac metabolic studies. Its high spatial and TOF resolution enable superior small lesion detectability, and its compact, air-cooled design is ideal for installations with limited space.
View uMI Panvivo →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SCENARIA View Phase | uMI Panvivo |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | On-premise | On-premise (scalable modality, departmental, or enterprise solution; compact design allows installation in smaller spaces without a dedicated equipment room). |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SCENARIA View Phase | uMI Panvivo |
|---|---|---|
| System Type | AI-powered CT system | AI-powered PET/CT system |
| Company | FUJIFILM Corporation | Shanghai United Imaging Healthcare Co., Ltd. |
| Key AI-powered Features | AI-based iterative reconstruction (Intelli IPV), Cardio StillShot for motion correction, AutoPose AI function | AI-powered workflow (uVision, EasyRange, OncoFocus, NeuroFocus, uExcel DPR) |
| Dose Management | Up to 83% dose reduction, DICOM Dose Structured Report and Dose Check (NEMA XR-25 compliant) | Not specified |
| Physical Design / Patient Comfort | Wide 80cm gantry aperture, 550lbs (250kg) table weight capacity, Auto Lateral Shift Table (u00b110cm) | Air-cooled compact design (fits in ~22mu00b2 rooms), Large tunnel clearance (up to 59cm), Ambient lighting with breathing guide, Collision-avoidance design |
| Image / Temporal Resolution | 28ms effective temporal resolution (Cardio StillShot) | High NEMA spatial resolution (2.9mm), Exceptional TOF timing resolution (219 ps) |
| Specialties Supported | Cardiology, Oncology, Radiology | Nuclear Medicine, Oncology, Radiology |
| Metal Artifact Reduction | HiMAR Plus metal artifact reduction | Not specified |
Videos
Demos, reviews, and walkthroughs featuring SCENARIA View Phase and uMI Panvivo.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
SCENARIA View Phase is an AI-powered CT system that provides detailed anatomical information, focusing on advanced CT imaging, dose reduction, and cardiac motion correction. In contrast, uMI Panvivo is an AI-powered PET/CT system, which combines both anatomical (CT) and functional (PET) imaging to reveal metabolic activity, offering advanced diagnostic precision, particularly in oncology, cardiology, and neurology.
SCENARIA View Phase features a wide 80cm gantry aperture and a 550lbs (250kg) table weight capacity with an Auto Lateral Shift Table for precise positioning and patient comfort. uMI Panvivo offers a large tunnel clearance of up to 59cm, ambient lighting with a breathing guide, and a collision-avoidance design to enhance patient comfort and safety.
SCENARIA View Phase includes AI-based iterative reconstruction (Intelli IPV) for up to 83% dose reduction and high image quality, Cardio StillShot for cardiac CT motion correction, and AutoPose AI for automatic scan range and dimension setting. uMI Panvivo offers AI-powered workflows such as uVision, EasyRange, OncoFocus, NeuroFocus, and uExcel DPR for intelligent operation, noise reduction, and enhanced image contrast.
SCENARIA View Phase emphasizes significant dose reduction, up to 83%, using AI-based iterative reconstruction and includes DICOM Dose Structured Report and Dose Check for dose reporting and awareness. uMI Panvivo highlights high NEMA spatial resolution (2.9mm) and exceptional TOF timing resolution (219 ps), which contributes to small lesion detectability and clarity, potentially allowing for lower dose usage and faster scan times.
uMI Panvivo features an air-cooled compact design that can fit in smaller rooms (~22mu00b2) without requiring a dedicated equipment room. It also includes lifetime software and functionality upgrades with an active service agreement and offers all-in configurations upfront. SCENARIA View Phase is an on-premise deployment, with pricing details not publicly available, though it also mentions a compact footprint.
SCENARIA View Phase specifically highlights Cardio StillShot for motion correction in cardiac CT, achieving 28ms effective temporal resolution, making it well-suited for cardiac CT angiography. uMI Panvivo lists cardiology as a specialty and offers high-resolution imaging, but does not detail specific cardiac motion correction features like Tool A, focusing more on functional assessment.
Both systems list oncology as a specialty. SCENARIA View Phase offers advanced CT imaging, including metal artifact reduction (HiMAR Plus), which can be beneficial in oncology for anatomical detail. uMI Panvivo, as a PET/CT system, provides advanced diagnostic precision by revealing metabolic activity, which is crucial for detecting and staging cancer, monitoring treatment effectiveness, and includes specific AI-powered workflows like OncoFocus to reduce respiratory motion artifacts for accurate quantification.